ロード中...
An Ecologically Valid, Longitudinal, and Unbiased Assessment of Treatment Efficacy in Alzheimer Disease (the EVALUATE-AD Trial): Proof-of-Concept Study
BACKGROUND: The current clinical trial assessment methodology relies on a combination of self-report measures, cognitive and physical function tests, and biomarkers. This methodology is limited by recall bias and recency effects in self-reporting and by assessments that are brief, episodic, and clin...
保存先:
| 出版年: | JMIR Res Protoc |
|---|---|
| 主要な著者: | , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
JMIR Publications
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7287724/ https://ncbi.nlm.nih.gov/pubmed/32459184 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2196/17603 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|